{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}

Charles C Roehr, Andrew SJ Marshall, Alexandra Scrivens, Manish Sadarangani, Rachel Williams, Jean Yong, Louise Linsell, Virginia Chiocchia, Jennifer L Bell, Caz Stokes, Patricia Santhanadass, Ian Nicoll, Eleri Adams, Andrew King, David Murray, Ursula Bowler, Kayleigh Stanbury & Edmund Juszczak.

Charles C Roehr ^1,2,*, Andrew SJ Marshall ¹, Alexandra Scrivens ^2,3, Manish Sadarangani ^4,5, Rachel Williams ², Jean Yong ³, Louise Linsell ², Virginia Chiocchia ², Jennifer L Bell ², Caz Stokes ⁶, Patricia Santhanadass ⁶, Ian Nicoll ³, Eleri Adams ³, Andrew King ², David Murray ², Ursula Bowler ², Kayleigh Stanbury ², Edmund Juszczak ^2,7

¹ Department of Paediatrics, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
² National Perinatal Epidemiology Unit, Clinical Trials Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
³ Newborn Care Unit, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK
⁴ Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, BC, Canada
⁵ Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada
⁶ Support for the Sick Newborn And their Parents (SSNAP) Charity, John Radcliffe Hospital, Oxford, UK
⁷ Nottingham Clinical Trials Unit, School of Medicine, University of Nottingham, Nottingham, UK
^* Corresponding author Email: charles.roehr@npeu.ox.ac.uk

Disclosure of interests

Full disclosure of interests: Completed ICMJE forms for all authors, including all related interests, are available in the toolkit on the NIHR Journals Library report publication page at https://doi.org/10.3310/THJY0671.

Primary conflicts of interest: Jennifer L Bell, Louise Linsell, Edmund Juszczak, Andrew King, David Murray, Kayleigh Stanbury and Manish Sadarangani report receipt of funding from NIHR, outside the submitted work. Charles C Roehr reports having received speaker’s bureau fees from Chiesi Pharmaceuticals (Parma, Italy) for themes outside the submitted work. Manish Sadarangani reports salary awards from the BC Children’s Hospital Foundation (Vancouver, BC, Canada), the Canadian Child Health Clinician Scientist Program (Toronto, ON, Canada) and the Michael Smith Foundation for Health Research (Vancouver, BC, Canada), and has been an investigator on projects funded by Pfizer Inc. (Pfizer Inc., New York, NY, USA), Merck KGAA (Darmstadt, Germany), VBI Vaccines Inc. (Cambridge, MA, USA), Seqirus Ltd (Parkville, VIC, Australia), Symvivo Corporation (Burnaby, BC, Canada), Sanofi-Pasteur (Lyon France) and GlaxoSmithKline plc (Brentford, UK). Edmund Juszczak was a member of the NIHR HTA General Board (2016–17) and the HTA Funding Committee (Commissioning) (2013–16), but was not involved in reviewing the NeoCLEAR funding application.